Pain Management Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Live Coverage of PAINWeek 2014

Exclusive access to live, onsite coverage of up-to-date evidence-based scientific findings in pain management.

IBD and Heavy Opioid Use

Clinicians should closely monitor the use of these medications in IBD treatment plans to reduce the risk of heavy subsequent use.

Pharmacies, Clinics Rx Drop-Off Sites

Attorney General Eric Holder stated that the new DEA regulation would help to prevent prescription drug misuse, particularly with opioid medications.

Aleve PM for Overnight Pain

Bayer HealthCare announced the launch of Aleve PM caplets for occasional sleeplessness associated with minor aches and pains.

Neck, Back Pain Improvement Factors

Observational registry-based research can inform patients and physicians about prognosis for subacute or chronic neck or low back pain.

Migraine Prophylactic Therapy

More research needs to be done to understand the reasons for non-adherence for migraine prophylactic therapy.

Pediatricians Prep for Anesthesia

Pediatricians have an important part in preparing surgical patients and their families for procedures, including anesthesia.

New Drug Product: Zubsolv

Maintenance treatment of opioid dependence, as part of a complete treatment plan to include counseling and psychosocial support.


Post-Op Pain Management Improved in Past Decade

The percentage of American patients who experience serious postoperative pain appears to have fallen significantly over the past decade, a new survey reveals.

How the Color of Drugs Influence Efficacy, Adherence

The color of a drug is more than just a way to make the pill appear attractive - it can also help to aid pill recognition for correct dosing by patients and protect light-sensitive products.

Breckenridge Launches Generic Ponstel

Breckenridge announced the launch of Mefenamic Acid 250mg capsules, the generic version of Shionogi's Ponstel.

Orexo Seeks to Expand Zubsolv Labeling

Orexo AB announced that it has submitted an application to the Food and Drug Administration (FDA) for an expanded label of Zubsolv (buprenorphine/naloxone) sublingual tablet CIII to include initiation of treatment for opioid dependence.

Anesthesia Complications Drop by Half in U.S.

Anesthesia-related complications in the United States have fallen by more than half, while the overall death rate has remained the same.

Featured courses from mycme

End-of-Life CareExternal web site

Discussing end-of-life issues and palliative care options with patients who have life-limiting illnesses is challenging. ...

CME|CE 1.25 Credits

Pitfalls in the Diagnosis and Treatment of Migraine HeadacheExternal web site

Migraine and other severe headaches are a common and major public health problem. Faculty presentations ...

CME 1.50 Credits

Pain Management Workshop (Pharmacology Credit)External web site

This program will discuss the causes of chronic pain as well as pharmacological options for ...

CE 3.00 Credits

Sign Up for Free e-newsletters